Keywords
Child
How to Cite
Abstract
Introduction: generalized pustular psoriasis (GPP) is a rare form of psoriasis in childhood characterized by aseptic neutrophilic pustules. The extent of the lesions and systemic involvement give variable severity. Its diagnosis is clinical and confirmed by histopathology.
Objectives: describe the diagnostic and therapeutic approach of a girl with GPP and share the questions regarding the etiology of the identified liver involvement.
Clinical case: 8 years old, with no pathological history, consulted for skin lesions such as scaly and pruritic plaques on the face, neck and trunk. No mucosal involvement, no fever. It was interpreted as infected atopic dermatitis. Clinical worsening under treatment. The plaques become erythematous, with pustules inside, spreading to the limbs. Referred by the GPP, she was admitted to hospital. Pathology anatomy confirmed subcorneal pustular dermatitis. In the evolution: regular general condition, worsening of the lesions, erythroderma and fever. Leukocytosis. Skin and blood culture without development. Treatment with retinoid (acitretin) was started, the lesions improved. On the third day, increase in liver transaminases. Acitretin was discontinued due to the suspicion of adverse effects. Discharged after 20 days, clinical and paraclinical improvement. A month later a new push without systemic commitment. Acitretin was reinstated, with positive progress.
Conclusions: the low frequency of GPG can lead to diagnostic delay. This case presented liver involvement as the initial systemic manifestation. The doubt that this presentation was a serious adverse effect of the retinoid confused clinicians and led to therapeutic changes.
References
Vicente A. Psoriasis en la infancia. An Pediatr Contin 2014; 12(6):348-54. doi: 10.1016/s1696-2818(14)70216-1.
Bronckers I, Paller A, van Geel M, van de Kerkhof P, Seyger M. Psoriasis in children and adolescents: diagnosis, management and comorbidities. Paediatr Drugs 2015; 17(5):373-84. doi: 10.1007/s40272-015-0137-1.
Peris K, Fortina A, Bianchi L, Fabbrocini G, Gisondi P, Balato A, et al. Update on the management of pediatric psoriasis: an italian consensus. Dermatol Ther (Heidelb) 2022; 12(8):1753-75. doi: 10.1007/s13555-022-00758-2.
Kalb E. Psoriasis pustulosa: patogenia, manifestaciones clínicas y diagnóstico. Junio 2022. En: Connor RF, ed. UpToDate. Riverwoods, Il.: Wolters K, 2025. Disponible en: https://www.uptodate.com/contents/pustular-psoriasis-pathogenesis-clinical-manifestations-and-diagnosis. (Consulta: 13 mayo 2024).
Augustin M, Glaeske G, Radtke M, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol 2010; 162(3):633-6. doi: 10.1111/j.1365-2133.2009.09593.x.
Gelfand J, Weinstein R, Porter S, Neimann A, Berlin J, Margolis D. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005; 141(12):1537-41. doi: 10.1001/archderm.141.12.1537.
Menter A, Cordoro K, Davis D, Kroshinsky D, Paller A, Armstrong A, et al. Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients. J Am Acad Dermatol 2020; 82(1):161-201. doi: 10.1016/j.jaad.2019.08.049.
Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, et al. Clinical and genetic differences between pustular psoriasis subtypes. J Allergy Clin Immunol 2019; 143(3):1021-6. doi: 10.1016/j.jaci.2018.06.038.
Bachelez H. Pustular psoriasis: the dawn of a new era. Acta Derm Venereol 2020; 100(3):adv00034. doi: 10.2340/00015555-3388.
Choon S, van de Kerkhof P, Gudjonsson J, de la Cruz C, Barker J, Morita A, et al. International consensus definition and diagnostic criteria for generalized pustular psoriasis from the International Psoriasis Council. JAMA Dermatol 2024; 160(7):758-68. doi: 10.1001/jamadermatol.2024.0915.
Guzmáz S, García A, Vega M. Psoriasis pustulosa generalizada. Dermatol Rev Mex 2023; 67(6):825-36. doi: 10.24245/drm/bmu.v67i6.9314.
Puig L, Choon S, Gottlieb A, Marrakchi S, Prinz J, Romiti R, et al. Generalized pustular psoriasis: a global Delphi consensus on clinical course, diagnosis, treatment goals and disease management. J Eur Acad Dermatol Venereol 2023; 37(4):737-52. doi: 10.1111/jdv.18851.
Johnston A, Xing X, Wolterink L, Barnes D, Yin Z, Reingold L, et al. IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol 2017; 140(1):109-20. doi: 10.1016/j.jaci.2016.08.056.
Bachelez H, Barker J, Burden A, Navarini A, Krueger J. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion. Expert Rev Clin Immunol 2022; 18(10):1033-47. doi: 10.1080/1744666X.2022.2116003.
Navarini A, Burden A, Capon F, Mrowietz U, Puig L, Köks S, et al. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 2017; 31(11):1792-9. doi: 10.1111/jdv.14386.
Fujita H, Terui T, Hayama K, Akiyama M, Ikeda S, Mabuchi T, et al. Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP. J Dermatol 2018; 45(11):1235-70. doi: 10.1111/1346-8138.14523.
Cabanillas M, Pérez L, Sánchez D, Toribio J. Psoriasis pustulosa generalizada y hepatitis citolítica asociada a colangitis neutrofílica. Actas Dermosifiliogr 2006; 97(5):330-3. doi:10.1016/s0001-7310(06)73412-3.
Burden A, Bissonnette R, Lebwohl M, Gloede T, Anatchkova M, Budhiarso I, et al. Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI). J Eur Acad Dermatol Venereol 2023; 37(7):1327-35. doi: 10.1111/jdv.18999.
de Jager M, de Jong E, van de Kerkhof P, Seyger M. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol 2010; 62(6):1013-30. doi: 10.1016/j.jaad.2009.06.048.
Huang Y, Tsai T. Pharmacological Management of Pediatric Pustular Psoriasis. Paediatr Drugs 2020; 22(3):265-77. doi: 10.1007/s40272-020-00383-6.
Dunn L, Gaar L, Yentzer B, O'Neill J, Feldman S. Acitretin in dermatology: a review. J Drugs Dermatol 2011; 10(7):772-82.
Carretero G, Ribera M, Belinchón I, Carrascosa J, Puig L, Ferrandiz C, et al. Acitretina: guía de uso en psoriasis. Actas Dermosifiliogr 2013; 104(7):598-616. doi: 10.1016/j.ad.2013.01.003.
Saikaly S, Mattes M. Biologics and pediatric generalized pustular psoriasis: an emerging therapeutic trend. Cureus 2016; 8(6):e652. doi: 10.7759/cureus.652.
Genovese G, Moltrasio C, Cassano N, Maronese C, Vena G, Marzano A. Pustular psoriasis: from pathophysiology to treatment. Biomedicines 2021; 9(12):1746. doi: 10.3390/biomedicines9121746.
Martínez M, Levrero P, Carusso R, Morales C, Arretche V, Nicola A, et al. Psoriasis vulgar moderada y severa: opciones terapéuticas (tratamientos convencionales). Arch Med Int 2013; 35(3):93-100.
Maçães C, Lé A, Torres T. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors. J Dermatolog Treat 2022; 33(7):2911-8. doi: 10.1080/09546634.2022.2089335.
Naik H, Pichard D, Schwartz D, O'Brien M, Masciocchi M, Thompson J, et al. Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial. J Am Acad Dermatol 2022; 87(6):1380-3. doi: 10.1016/j.jaad.2022.07.065.
Blair H. Spesolimab: first approval. Drugs 2022; 82(17):1681-6. doi: 10.1007/s40265-022-01801-4.
Vilarrasa E, Rivera R, Eiris N, Carretero G, de la Cueva P, Carrascosa J. Aproximación a la epidemiología, manejo de la enfermedad y retos actuales en la gestión de la psoriasis pustulosa generalizada en España a través de un cuestionario dirigido a dermatólogos. Actas Dermosifiliogr 2024; 115(5):449-57. doi:10.1016/j.ad.2023.10.022.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Archives of Pediatrics of Uruguay